RepAir specializes in large-scale carbon removal technology. Its fully electric, zero-heat process efficiently separates CO2 from air using minimal energy, producing no hazardous waste or liquids.
Brain.space is a data company focused on brain mapping, aiming to support researchers, medical professionals, and software developers in interpreting and analyzing brain activity. The company offers a comprehensive and affordable technology stack that includes noninvasive brain activity mapping and monitoring, along with validated big data interpretation and insights. This platform enables users to develop innovative products and services that leverage brain activity data, facilitating advancements in various fields related to neuroscience and mental health.
QuamCore
Seed Round in 2025
We're Building the Next Big Thing
nT-Tao Compact Fusion Power
Grant in 2025
nT-Tao is building a compact fusion reactor that will generate 10-20 MW of electricity. The reactor is highly scalable and will be about the size of a shipping container, ensuring clean fusion energy wherever needed. The reactor’s scalability and affordability will make it suitable for various power needs, ranging from industrial and manufacturing facilities to small towns and off-grid locations. This scalability coupled with the ability for rapid deployment, positions nT-Tao’s reactor as a versatile and adaptable fusion energy solution.
nT-Tao’s unique solution relies on a proprietary plasma heating method which is expected to reach 1000 times higher density than other fusion reactors, thereby making its fusion reaction 1 million times more effective. nT-Tao’s ability for quick development iterations and its groundbreaking approach, dramatically reduces the size, cost, and complexity of fusion energy reactors. Co-founded by Oded Gour-Lavie, Doron Weinfeld, and Boaz Weinfeld, nT-Tao’s mission is to develop a unique nuclear fusion technology that will enable the world to transition towards a cleaner, decarbonized, sustainable, and advanced future.
IBI-Ag is a biotechnology company developing bioinsecticides using environmentally friendly technology. It focuses on discovering and developing selective, safe, and cost-effective biological solutions to control insects and increase crop production worldwide.
Lowental Hybrid
Seed Round in 2025
Lowental Hybrid specializes in developing hybrid propulsion systems for Unmanned Aerial Vehicles (UAVs). Their technology combines fuel-based propulsion with electric power, allowing UAVs to operate for longer durations while maintaining the low noise levels of electric systems. The company's advanced parallel hybrid solution, comprising an electric motor and an internal combustion engine, enables vertical take-off using electricity and extends flight times up to fivefold, making it ideal for extended and demanding missions.
Promise Bio is a biotechnology company specializing in precision medicine for autoimmune diseases. It leverages epiproteomic analysis, a cutting-edge technique that examines protein modifications, using a cloud-based AI platform to interpret standard mass-spectrometry data. This innovative approach aims to uncover disease mechanisms and facilitate personalized treatment plans, ultimately improving patient care and affordability.
MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.
i-EcoGuard
Seed Round in 2024
i-EcoGuard specializes in sustainable agriculture, utilizing advanced nanoparticle technology to enhance greenhouse efficiency. The company's core product is an innovative, self-adapting polymer that optimizes greenhouse conditions, promoting plant health, improving crop quality, and boosting energy efficiency.
Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.
Eretz Angels
Grant in 2024
Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.
Lidwave is a developer of advanced 3D sensing solutions aimed at transforming industries reliant on LiDAR technology. By introducing a novel three-dimensional sensing architecture, the company addresses significant limitations in traditional LiDAR and radar systems, particularly concerning bandwidth constraints. Its innovative Finite Coherence Ranging (FCR) technology delivers enhanced four-dimensional sensing capabilities, enabling precise Doppler and depth information. This breakthrough allows businesses to enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities, ultimately facilitating smarter and safer decision-making. Lidwave's approach not only resolves the challenges associated with existing sensing methods but also positions it as a leader in disruptive sensing technology.
Lavie Bio develops microbiome-based agricultural products, including bacterial compositions sprayed on plants, seed coatings, or soil amendments, to enhance crop performance. The portfolio includes bio-stimulants, bio-pesticides, biocontrol agents, and bio-inoculants derived from natural microbial sources to improve nutrient uptake and assimilation, enabling farmers to increase yield and crop quality. By harnessing beneficial microorganisms, Lavie Bio pursues sustainable alternatives to conventional inputs across diverse crops.
Pickommerce AI Robotics
Seed Round in 2024
Pickommerce is revolutionizing e-commerce logistics with its autonomous pick-and-pack robotic system, PickoBot. This innovative solution addresses labor constraints in the growing e-commerce sector by streamlining the picking and packing process. PickoBot's advanced computer vision system, powered by machine learning, allows it to handle a vast array of items with various grippers and packing algorithms. This adaptable technology seamlessly integrates into both automated and conventional warehouses, minimizing disruption while boosting efficiency and productivity. Pickommerce's patented adhesive picking methods and AI-driven decision-making algorithms ensure optimal grasp configuration and package box optimization.
SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems.
SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses.
SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.
TruLeaf Medical
Grant in 2024
TruLeaf Medical is a developer of user-friendly Transcatheter Mitral Valve Replacement (TMVR) solution.
IR-MED LTD. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company leverages advanced technologies, including big data and machine learning, to create innovative diagnostic modalities. IR-MED develops continuous and real-time monitoring devices capable of detecting and measuring various substances and pharmaceuticals in the blood. Additionally, their systems can assess fluid concentrations on surfaces and behind thin tissues, facilitating the identification and characterization of medical lesions and pathological processes in humans.
Ocon Healthcare
Grant in 2024
OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.
Eight Two Hundred Angels
Grant in 2024
Eight Two Hundred Angels is an investment firm, They assist in promoting the companies in which they invest, attract investors, and qualify investors interested in investing in innovative technologies and high-risk investments.
TEClub VC is an investment firm for mega angels that invests in breakthrough technologies at early stages through a smart and selective investment platform. They focus on creating unicorn companies and venture creation models.
Nugen Clean Energy
Grant in 2024
Nugen Clean Energy specializes in off-grid electric vehicle (EV) charging systems. Their innovative technology uses a solid-state hydrogen compound to safely generate and utilize hydrogen on-site and on-demand, ensuring a reliable and sustainable power source even in remote locations. This enhances grid capacity and provides uninterrupted charging, making EV charging infrastructure more scalable and dependable.
Qualifire
Pre Seed Round in 2024
Qualifire is a real-time safety and quality control platform for LLM-based applications. It intercepts and blocks inaccuracies, hallucinations, and policy violations in real time, safeguarding brand integrity and regulatory compliance. Qualifire supports the entire AI lifecycle from training to deployment, empowering teams to confidently deploy AI that adheres to business and regulatory requirements.
AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.
Soltell Systems
Grant in 2024
Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.
Sequentify develops innovative technology that combines synthetic biology and AI software tools for targeted DNA sequencing applications. These include cancer diagnostics, carrier screening, COVID-19 surveillance, and other genomic research areas.
FireDome's revolutionary wildfire defense system takes a two-tiered strategy. First, a mechanical launcher quickly deploys a protective barrier to impede the direct route of advancing wildfires. Second, the system actively detects and promptly extinguishes spot fires created by airborne embers that bypass the primary barrier.
Charging Robotics
Grant in 2023
Charging Robotics engages in wireless charging solutions.
NurExone Biologic
Grant in 2023
NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.
Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.
CODA is a cloud-based AI platform that translates spoken language into sign language and provides the deaf community with easier access to video content in their preferred language.
Maris-Tech is a global leader in video and AI-based edge computing technology, pioneering intelligent video transmission solutions that conquer complex encoding-decoding challenges. Our miniature, lightweight, and low-power products deliver high-performance capabilities including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics. Founded by Israel technology sector veterans, Maris-Tech serves leading manufacturers worldwide in defense, aerospace, Intelligence gathering, homeland security (HLS) and communication industries worldwide. We’re pushing the boundaries of video transmission and edge computing, driving innovation in mission-critical applications across commercial and defense sectors.
Microbot Medical
Grant in 2023
Microbot Medical is a medical device company based in Hingham, Massachusetts, founded in 2010. It specializes in developing micro-robotic technologies for minimally invasive surgery. The company's key products include the Self Cleaning Shunt (SCS) for treating hydrocephalus and normal pressure hydrocephalus, TipCAT, a self-propelling endoscope initially designed for colonoscopy procedures, and Liberty, a combination of guidewire and microcatheter technologies for endoluminal surgery. Microbot Medical aims to enhance surgical outcomes by providing less invasive and more precise solutions, with 37 issued/allowed patents and 15 patent applications pending worldwide.
Pashoot Robotics
Grant in 2023
Pashoot Robotics specializes in contextual robotics for manufacturing. It develops AI-Robotics software that enables robotic arms to learn and adapt to their environment, moving beyond pre-programmed tasks. This enhances production productivity and competitiveness.
SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems.
SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses.
SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.
EMRIS Pharma
Pre Seed Round in 2023
EMRIS Pharma takes care of the life and treatment compliance for cancer patients.
BloomX is an AI pollination solution for crops in which pollination is a limiting factor for their yield. The company allows growers to increase their revenue by enlarging yields in existing crops and improving fruit quality.
BloomX's vision is to provide an AI-based pollination solution that addresses each crop’s pollination needs by mimicking the natural pollination process and enhancing it using technology. Bumblebee was founded in 2019 and is headquartered in Tel Aviv, Israel.
MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.
UB Therapeutics
Pre Seed Round in 2023
UB Therapeutics is a biotechnology company developing a novel therapy for the treatment of multiple myeloma.
Atiko Labs
Pre Seed Round in 2023
Atiko Labs specializes in creating innovative robotic solutions to address various challenges in agriculture, focusing on farming autonomy. The company designs and develops smart, custom-made robots that function like farmers, aiming to enhance efficiency and productivity in the agricultural sector. Additionally, Atiko Labs has developed a portable optical sensor capable of detecting materials or contaminants in production line samples. This technology provides rapid, high-resolution detection with accurate results delivered within seconds. The data collected is securely stored and analyzed in the cloud, allowing clients to identify target molecules on-site, thereby streamlining quality control processes in their operations.
Nina Medical
Seed Round in 2023
Nina Medical specializes in advancing innovations for non-invasive surgery, focusing on a diagnostic-therapeutic system for treating benign prostatic hyperplasia (BPH) in office settings using high-intensity focused ultrasound (HIFU).
Oversight is a company that develops a 3D collaborative workspace platform aimed at enhancing decision-making for first responders. Its innovative platform integrates advanced artificial intelligence simulations and real-time data management from various devices, including drones, body cameras, and smartphones. This functionality allows emergency response teams to achieve comprehensive situational awareness, thereby improving mission planning and operational efficiency. By fusing diverse data sources into a single interactive environment, Oversight empowers clients to make informed decisions during critical situations, ultimately supporting their efforts in emergency response.
Dio Tree
Seed Round in 2022
DioTree is a biotechnology company specializing in the development of innovative treatments for high-grade serous ovarian cancer (HGSOC). The company's core focus is to inhibit the enzyme DIO3, which plays a significant role in driving ovarian cancer progression, by utilizing a novel mechanism of action and small molecule technology. DioTree aims to advance cancer treatment frontiers, enabling medical professionals to provide more effective care and positively impacting the lives of those affected by this disease.
Enzymit
Non Equity Assistance in 2022
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.
Navina develops an AI-driven platform that restructures patient data into intuitive patient portraits, enabling physicians to assess complex cases swiftly. This improves patient wellness and enhances financial performance for providers and payers.
BioBetter
Series A in 2022
BioBetter is a biotechnology company that develops plant-based platforms for producing complex growth factors used in cultivated meat and for simplifying protein manufacturing and purification for biopharmaceuticals. The platform uses transgenic plants as bioreactors to express therapeutic proteins and co-expresses enzymes that remove antigenic sugars to improve protein quality and reduce production costs. By leveraging plant biology, BioBetter targets lower-cost biotech production across cultivated meat and biotech applications. The company was founded in 2015 and is headquartered in Israel.
VREE LABS
Pre Seed Round in 2022
VRee AI develops state of the art 3D technologies based on AI methods such as NeRF and deep learning, to generate 3D models for AR/VR environments. We basically help turning 2D images into 3D models in the blink of an AI.
Founded in 2015, SuperMeat is an Israeli biotech and food-tech company that produces cultured meat from chicken cells in a controlled environment. This process reduces land use by 99% and water consumption by 90%, minimizing environmental impact while ensuring food safety without antibiotics.
VALFIX Medical
Grant in 2022
VALFIX Medical is a Tel Aviv-based medical device company focused on transcatheter solutions for repairing and replacing the mitral and tricuspid valves, using multi-wire technology to provide a complete transcatheter repair and replacement approach, offering an alternative to open-heart surgery and addressing heart failure symptoms by eliminating mitral regurgitation.
Brevel develops innovative cultivation technology for sustainable, low-cost production of microalgae. Its high-tech, indoor, automated systems use internal illumination to achieve over 90% cost reduction and up to 200 times higher yields compared to traditional methods. Brevel targets various markets where microalgae-derived products are in demand.
Enlivex Therapeutics
Grant in 2022
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.
Olive Diagnostics
Seed Round in 2022
Olive Diagnostics is a company that has developed an innovative passive urine analysis sensor designed to enhance early disease detection and chronic disease management. This sensor, which can be easily mounted to any toilet, utilizes spectroscopy combined with artificial intelligence-based analytics to monitor the urine stream. By continuously collecting and analyzing health data, the device provides users with real-time health alerts that promote awareness of their bodily functions. The technology not only supports individual health management but also offers valuable insights for pharmaceutical and contract research organizations to track drug compliance and usage. With its focus on proactive health monitoring, Olive Diagnostics aims to make urine lab services accessible even in nonindustrial nations, thereby transforming personal health care through advanced, continuous biomarker tracking.
Gemma is focused on revolutionizing the makeup experience for women by developing an automatic makeup application machine. This innovative device simplifies the process of applying makeup, enabling users to achieve various looks in under two minutes using automated airbrush technology and real-time color mixing. Gemma's patented technology empowers women to select their desired makeup look, essentially providing the benefits of a professional makeup artist in the comfort of their own homes. By streamlining makeup application, Gemma aims to enhance the confidence and convenience for busy individuals seeking a quick and effective beauty solution.
Cybord develops technology to prevent counterfeit, defective, or malicious electronic components from being assembled into products during manufacturing. It integrates with manufacturing equipment, using deep learning algorithms and a global component database to rate each component.
AccuLine is a digital health company dedicated to early detection of coronary artery disease. It develops CORA, a smart, accurate, and user-friendly exam designed to replace traditional ECG stress tests, enabling healthcare providers to prevent heart attacks more effectively.
DermaDetect
Seed Round in 2022
DermaDetect is a developer of an AI-driven digital dermatology platform that focuses on the analysis and management of skin disorders, including non-pigmented lesions and acute diseases. The platform allows patients to conduct self-assessments of their skin, hair, and nails, facilitating remote diagnosis and treatment of various skin conditions. By automatically detecting skin issues, DermaDetect not only recommends appropriate treatments but also connects patients with nearby physicians, ensuring they receive timely care from the comfort of their homes. This innovative approach empowers individuals to manage their dermatological health effectively and conveniently.
DermaDetect
Seed Round in 2022
DermaDetect is a developer of an AI-driven digital dermatology platform that focuses on the analysis and management of skin disorders, including non-pigmented lesions and acute diseases. The platform allows patients to conduct self-assessments of their skin, hair, and nails, facilitating remote diagnosis and treatment of various skin conditions. By automatically detecting skin issues, DermaDetect not only recommends appropriate treatments but also connects patients with nearby physicians, ensuring they receive timely care from the comfort of their homes. This innovative approach empowers individuals to manage their dermatological health effectively and conveniently.
Alumor develops solar-powered water purification technology devices based on ultraviolet LED light which can purify any type of surface water, including lakes, rivers, lagoons, and pools.
MagniLearn
Seed Round in 2021
MagniLearn is an innovative startup that offers personalized educational experiences. It employs artificial intelligence and natural language processing to create tailored learning materials for students, dynamically adjusting lessons based on individual progress.
YieldX Solutions
Pre Seed Round in 2021
Precision Ag-Biosecurity Data Platform For Livestock Farming.
BeeHero develops a beehive technology platform that aims to increase crop yields by enhancing pollination. The platform combines artificial intelligence, machine learning, and in-hive sensors to collect data and optimize pollination during peak cycles, helping farmers protect hives from colony collapse and maximize pollination efficiency for growers worldwide. Founded in 2017, the company operates from Tel Aviv and Silicon Valley and focuses on providing data-driven insights and automation to support pollination across agricultural environments.
Kipp Authorize More
Grant in 2021
Kipp enables card issuers and merchants to approve more transactions, leading to higher customer satisfaction and greater revenue.
Kipp's platform serves and supports issuer banks in optimizing their cards' business, leveraging their relationships with merchants, their willingness to share data and participate in the cost of risk.
Silib
Venture Round in 2021
Silib is a battery manufacturing company that specializes in developing advanced pure silicon anodes for lithium-ion batteries. By utilizing a novel, low-cost manufacturing process that does not require catalysts, precious metals, or binders, Silib's anodes can enhance battery capacity by over 40%, achieving energy densities exceeding 1000Wh/L. The company's unique nanostructured silicon technology allows for high mass loading, which enables a reduction in battery size while maintaining the same energy content or improving capacity. Silib's anodes are designed to be compatible with any cell format, serving as a drop-in replacement for traditional graphite-based anodes, thereby providing significant advantages in battery performance.
Ripe Guard
Seed Round in 2021
Ripe Guard develops a technology platform aimed at predicting the shelf life of fruits and vegetables. This reduces waste in the $2.3 trillion industry, where up to 45% of produce is typically discarded. The platform enables accurate predictions of ripening and spoilage dates, leading to cost savings, improved efficiency, increased food supplies, and enhanced sustainability.
Tiktalk To Me
Series A in 2021
Tiktalk To Me owns and operates a digital health company intended to offer a platform for speech therapy. Its platform functions as a virtual speech therapist, guiding patients through proven and widely accepted training protocols using online games supervised by the patient's personal speech therapist and combines gaming with speech- and voice-recognition technology, enabling speech-language pathologists to shorten the treatment cycle and save substantial time and money for the patients.
Growee develops an electronic hydroponics system and cloud-based analytics platform designed for home gardeners and urban farmers. The device automates nutrient distribution and pH balancing, monitors water and air conditions, and can be wall-mounted for easy installation, with control accessible from computers or smartphones. Through real-time sensing and precise feeding algorithms, Growee aims to simplify hydroponics for users of all experience levels while enabling advanced growers to optimize crop rotation and yields. The integrated growth analytics platform provides insights to improve efficiency, reduce resource use, and support sustainable, local food production. By increasing yield, reducing nutrient costs, conserving water, and lowering CO2 emissions, Growee positions itself as a practical solution for growing fresh produce in homes, rooftops, and compact urban spaces.
Mush Foods
Pre Seed Round in 2021
Mush Foods is a New York-based food technology company that cultivates edible mushroom mycelium. Its flagship product, 50CUT, integrates seamlessly with real animal meat, reducing the carbon footprint by half while enhancing nutrition and taste.
IBI-Ag is a biotechnology company developing bioinsecticides using environmentally friendly technology. It focuses on discovering and developing selective, safe, and cost-effective biological solutions to control insects and increase crop production worldwide.
ViAqua Therapeutics
Grant in 2021
Founded in 2014, ViAqua Therapeutics is based in Israel. The company specializes in developing drugs and therapeutics for aquaculture, focusing on the first orally administered treatment to prevent viral diseases.
Ark Surgical
Seed Round in 2021
Ark Surgical is a commercial-stage medical device start-up that specializes in laparoscopic surgery. The company is dedicated to developing and commercializing innovative solutions that enhance safety during minimally invasive procedures. Its flagship product, LapBox, is a user-friendly containment system designed to prevent the dispersion of cancerous tissue during surgeries, particularly in the context of women's health. This device has received FDA clearance, and a second iteration is in development. By facilitating the contained removal of large internal organs through laparoscopic keyhole incisions, Ark Surgical's products significantly reduce the risks associated with traditional tissue morcellation, allowing surgeons to perform safer and more effective minimally invasive surgeries.
CorrActions
Seed Round in 2021
CorrActions develops an AI-driven platform that interprets and translates human brain signals in real-time. This enables smarter machines across aviation, automotive, medical, and tech industries, enhancing human-machine interaction efficiency.
Enlivex Therapeutics
Grant in 2021
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.
Skip Therapeutics
Seed Round in 2021
Skip Therapeutics is a biotechnology company focused on developing precision, RNA-based treatments for rare genetic diseases. With millions of people affected by various rare genetic disorders, the company aims to overcome challenges in treatment discovery caused by limited patient populations and specific mutations. By leveraging recent advancements in RNA therapeutics, Skip Therapeutics utilizes splice-modulating antisense oligonucleotides to analyze mutation data at scale. This approach enables the identification of treatable patient cohorts, optimizes target selection, and recognizes effective molecular strategies to restore protein function. Through computational techniques, the company seeks to match RNA-based therapeutic options to the vast landscape of known disease-causing mutations, thereby enhancing the potential for tailored medical interventions.
AQUALITAS
Pre Seed Round in 2021
Aqualitas specializes in developing a modular water quality monitoring system that operates continuously and requires minimal maintenance. Their platform allows customers to select specific physicochemical parameters for monitoring, while the system utilizes self-diagnosis and automated processes to streamline operations. By leveraging Internet of Things (IoT) technology, Aqualitas collects real-time water quality data, which is analyzed and transformed into actionable insights delivered to users through a software-as-a-service (SaaS) platform. This approach eliminates the need for an initial investment in equipment, enabling customers to expand their monitoring capabilities as their needs grow. Aqualitas's use of artificial intelligence and machine learning further enhances the system by ensuring sensor operational stability and automatic calibration, ultimately resulting in lower costs and improved efficiency for industries reliant on accurate water quality data.
Spectalix empowers brands to reclaim and monetize their digital assets by integrating a unique white-label UGC platform. This platform enables users to engage with brand content using their mobile devices, creating personalized videos that can be shared on social media. Spectalix ensures brand safety through automated moderation.
ZygoFix
Seed Round in 2021
ZygoFix is a medical device company specializing in spine technology. It has developed an innovative three-dimensional-printed implant designed to lock the facet joint of the lumbar spine. This device leverages the anatomy of the spine to provide stability, eliminating the need for traditional external screw-based bridges and reducing the reliance on pedicle screws. By doing so, ZygoFix aims to minimize the risks associated with improper screw placement, thereby enhancing safety in spinal surgeries. The company's focus on advancing spinal stability reflects its commitment to improving patient outcomes in the medical field.
Anicca is a mental health company focused on developing innovative technology for managing stress and emotional well-being. The company has created a wearable device that features a smart respiration sensor, which measures users' breathing patterns. This device also incorporates a tactile stimulation mechanism that delivers haptic feedback through pleasant vibrations synchronized with the user's breathing. By promoting better focus, improved sleep, and reduced anxiety, Anicca's product aims to provide users with an effective tool for on-the-go emotion and stress management.
Flytrex is the leading drone-based food delivery service in the United States, specializing in ultrafast deliveries from local restaurants to suburban areas. Operating in North Carolina and Texas, Flytrex has successfully delivered over 120,000 orders for its partners, including Little Caesars, Papa John's, and El Pollo Loco. The company's service is well-received by customers, with a monthly retention rate of 45% after two years, and an NPS score of 75%. Flytrex's drone delivery system significantly reduces delivery costs and times for its partners.
FertilAI is a healthcare company based in Israel that develops AI-driven technologies to enhance fertility treatments. Its platform, Fertilane, automates clinical decision-making processes for physicians and facilitates communication among clinics, doctors, and patients through tailored apps and web platforms.
ThermoTerra
Seed Round in 2020
ThermoTerra captures a new source of renewable energy, powered by natural fluctuations in humidity - Humidity Power - to heat and cool build.
Enzymit
Non Equity Assistance in 2020
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.
Phytolon
Funding Round in 2020
Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.
High Lander
Seed Round in 2020
High Lander is a technology company that specializes in converting off-the-shelf drones into pilot-less, autonomous systems through its innovative software solution. Its Mission Control platform enables users to manage a fleet of drones, enhancing operational efficiency in various applications such as first response, aerial security, and precision agriculture. Additionally, High Lander develops drone flight plan technology that addresses the challenge of short battery life, allowing for the establishment of commercial drone airports. These facilities enable users to host, recharge, and effectively deploy drones to their designated locations, further expanding the capabilities of unmanned aerial vehicles in diverse mission scenarios.
Vessi Medical
Venture Round in 2020
Vessi Medical is an Israeli medical device startup focused on innovating treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC) through a novel surface cryotherapy approach. This technique employs extreme cold to freeze and eliminate abnormal tissue, providing a minimally invasive alternative to the standard TransUrethral Resection of Bladder Tumor (TURBT), which is often inadequate and requires invasive surgery under general anesthesia. Vessi's technology, comprising a standalone console and a disposable catheter, allows for targeted cell destruction while safeguarding healthy bladder tissue. This office-based procedure not only reduces the need for costly hospital stays and repeat surgeries but also addresses the high recurrence rate of NMIBC, which affects millions globally. With promising proof of concept already demonstrated in animal studies, Vessi aims to capture the $1.2 billion NMIBC market, while also exploring future applications for treating overactive bladder and urinary tract infections. The company is supported by experienced professionals in the medical device and cryotherapy sectors, ensuring a strong foundation for its innovations.
Soltell Systems
Grant in 2020
Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.
RFISee is focused on developing innovative radar technology aimed at enhancing the safety of autonomous vehicles. The company is creating the world's first 4D imaging radar on a single chip, which utilizes high-resolution, low-cost radar sensors to produce real-time 3D location and velocity maps of surrounding objects. This advanced technology is designed to support the automation of driving, paving the way for safer vehicles and enabling new transportation modes and business models. RFISee's radar systems are particularly beneficial due to their robustness, functioning effectively in various weather and light conditions, a characteristic that aligns with the needs of the rapidly growing autonomous car market.
Magentiq Eye
Non Equity Assistance in 2020
Magentiq Eye Ltd., established in 2014, specializes in developing AI-driven medical devices for endoscopic procedures. Its flagship product is the Automatic Polyp Detection System (APDS), which uses computer vision and deep learning to assist doctors in real-time colonoscopy examinations, aiming to reduce polyp miss-rates and improve patient outcomes.
SafeUP - Women's Safety Net
Pre Seed Round in 2020
90 days from launch (Dec 20):
- 4 paying clients in 90 days, 25 days sales cycle.
- 10,000 users covering all 10 largest cities of Israel.
Together with our SafeUPer we - Create a Safe World for Women - One community at a time.
Create – We believe people must take an action, getting out of our comfort zone, to achieve this change. Sharing stories is simply not enough.
Safe – We believe being safe is a basic right of all women, and like all women right achieved by previous generations, it will be gained with sweat and tears.
World – We are facing a global problem, documented for at least two millennia (2,000 yrs), maybe the only problem impacting women daily, of all ages, countries, backgrounds and beliefs. Therefore. We believe it should be solved globally, empowering women all around the world to bring safety to their local communities.
Women – We believe that when women will have peace, men too will have peace. Men have proven that they are unable to bring peace and safety by themselves to themselves nor to women. Therefore, we need to lead and bring it together.
Baseline Vision
Grant in 2020
Baseline Vision is a developer of a cloud-based game analytics platform tailored for the net-sports market, with a primary focus on tennis. The company offers a scalable solution that utilizes a single portable smart-camera device to deliver real-time game analysis. This innovative technology unlocks a range of digital products, including line-calling, performance tracking, on-court gamification, and video feedback. Through its platform, Baseline Vision enables tennis players and coaches to review past training sessions, monitor their progress, connect with other players, and share content on social media. The integration of these features enhances the training experience and fosters a community among users.
DiA Imaging Analysis
Grant in 2020
DiA Imaging Analysis Ltd. is a technology company based in Beersheba, Israel, specializing in AI-powered ultrasound analysis designed to enhance the evaluation of cardiac function and other medical conditions. Founded in 2009, DiA offers a range of innovative applications, including LVivo EF for automated ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain, which assesses myocardial strain as an early indicator of reduced left ventricular function. Their tools simplify the ultrasound imaging process by providing automated analysis and optimal view selection, improving the diagnostic capabilities of clinicians. DiA's technology is compatible with various ultrasound devices and healthcare IT systems, streamlining the detection of clinical abnormalities. The company holds FDA and CE clearances and serves thousands of users globally, addressing critical challenges in ultrasound utilization by enabling more accurate and efficient image analysis through advanced pattern recognition and machine learning algorithms.
XRHealth Ltd. is a medical technology company based in Tel Aviv, Israel, that specializes in developing virtual reality (VR) software solutions for healthcare. Founded in 2016, the company offers an array of products designed to enhance patient care and treatment outcomes. Its offerings include VRPhysio, a platform for virtual physical therapy; VRReliever, which helps manage pain through distraction; VRCogni, aimed at improving motor function in stroke and dementia patients; and VRPsyc, which provides exposure therapy for various mental health disorders. Additionally, VRCoordi is designed to aid coordination recovery in patients with Parkinson's, brain injuries, and autism. By integrating immersive technologies with licensed clinicians and advanced data analytics, XRHealth provides comprehensive telehealth services, allowing patients to access treatment from the comfort of their own homes.
Caaresys
Seed Round in 2020
Caaresys is a developer of advanced vehicle passenger monitoring systems aimed at preventing vehicle-related tragedies. The company's innovative technology utilizes a contactless low-emission radio frequency radar to monitor vehicle occupancy and vital signs, including heart rate and respiratory rate. This system is designed to activate warnings on a paired mobile device and trigger the car alarm when necessary, enabling users to detect potential dangers early and take appropriate precautions. Caaresys has established partnerships with leading suppliers and has secured licensing agreements for significant deployment within the automotive sector. The company is engaged in multiple projects across various domains, including automotive applications, aftermarket solutions such as child detection systems for school buses, and health monitoring initiatives, including vital signs monitoring in medical beds and COVID test stations. Its patented technology, developed by an in-house team of experts, positions Caaresys as a preferred vendor within the industry.
Cymptom is a cybersecurity company that offers a platform designed to protect organizations from cyber breaches by proactively assessing and visualizing potential attack paths. Utilizing agentless data collection technology, Cymptom maps critical risks to the MITRE ATT&CK® framework, enabling continuous monitoring of both on-premises and cloud environments. The platform identifies breach scenarios and pinpoints vulnerabilities without the need for attack simulations or interference with existing security measures. This approach allows organizations to receive real-time assessments of their security posture, prioritize mitigation strategies, and maintain operational continuity. By providing always-on cyber resilience, Cymptom supports business initiatives while minimizing the risk of cyber threats.
Enlivex Therapeutics
Grant in 2020
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.
Nobio Ltd. is a biotechnology company based in Petah Tikva, Israel, specializing in the development of innovative nano-polymer additives that provide protection against microbial infections. Its technology enables the transformation of both implantable and non-implantable devices into biofilm-resistant platforms. Nobio's product offerings include a universal bonding agent designed for strong adhesion to various dental surfaces and restorative materials, as well as flowable composites suitable for dental restorations and sealants. The core of Nobio's technology consists of potent particles embedded with highly-active antimicrobial structures that kill bacteria upon contact, effectively preventing medical device contamination indefinitely. This unique approach positions Nobio as a leader in the creation of durable antimicrobial materials and surfaces, enhancing safety and efficacy in medical and dental applications.
AgroScout
Seed Round in 2020
AgroScout Ltd. is an Israeli company established in 2017 that specializes in developing an artificial intelligence-based platform aimed at enhancing sustainable farming practices. The company's technology provides precision agriculture solutions by utilizing advanced analytics and high-resolution aerial imagery to assess crop health and monitor for pests and diseases. AgroScout's platform supports farmers by offering insights on crop emergence, stand counts, canopy coverage, and biomass throughout the growing season. This continuous monitoring allows for early detection of infestations, enabling more effective curative treatments and reducing pesticide use. By delivering actionable insights into crop management and regional outbreak predictions, AgroScout aims to improve crop yields and profitability while fostering a more sustainable food production supply chain.
BrainStorm Cell Therapeutics
Grant in 2020
BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.
Aquafit Intimate
Seed Round in 2020
Aquafit Intimate is a pioneer in the field of intimate wellness. Our mission is to empower women to take control of their intimate wellness through self-care, for women of all ages.
- An ask anything AI companion for personalised gynae wellness self assessments and getting help.
- Our flagship Intimate Gel Stick family, which combines vaginal muscle training with the delivery of natural extracts to help restore elasticity, hydration, and pH balance for pain-free intimacy.
Our products and services address very common intimate wellness conditions, central to women's health and wellbeing.
Indoor Robotics
Grant in 2020
Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.
Brevel develops innovative cultivation technology for sustainable, low-cost production of microalgae. Its high-tech, indoor, automated systems use internal illumination to achieve over 90% cost reduction and up to 200 times higher yields compared to traditional methods. Brevel targets various markets where microalgae-derived products are in demand.
TaTiO
Pre Seed Round in 2020
TaTiO is a company that specializes in enhancing the recruitment process through its innovative virtual job simulation application. By leveraging AI technology, TaTiO allows candidates to experience job roles in a simulated environment, fostering an emotional connection to the position. This approach not only screens candidates based on their actual skills but also matches them with suitable job opportunities. As a result, TaTiO helps businesses optimize their hiring processes by increasing application and engagement rates, thereby improving the quality of leads and significantly reducing candidate drop-off rates. Through its unique methodology, TaTiO aims to create a more effective and engaging recruitment experience for both employers and candidates.